ALVA 1 (Uricalm phenazopyridine hydrochloride 99.5 mg)
Generic Name: phenazopyridine
Pill imprint ALVA 1 has been identified as Uricalm phenazopyridine hydrochloride 99.5 mg.
Uricalm is used in the treatment of interstitial cystitis; dysuria and belongs to the drug class miscellaneous genitourinary tract agents. There is no proven risk in humans during pregnancy. Uricalm phenazopyridine hydrochloride 99.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ALVA 1
- phenazopyridine hydrochloride 99.5 mg
- Rx and/or OTC
- Drug Class:
- Miscellaneous genitourinary tract agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Alva-Amco Pharmacal Companies, Inc
- National Drug Code (NDC):
- Inactive Ingredients:
FD&C Red No. 40
FD&C Yellow No. 6
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about Uricalm (phenazopyridine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 16 Reviews – Add your own review/rating
- Drug class: miscellaneous genitourinary tract agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.